Growth investing is the philosophy of buying companies whose revenue, earnings, or cash flow are expected to expand materially faster than the broad market, on the conviction that compounding fundamentals — not a cheap entry multiple — will drive the return. Growth investors deliberately accept above-average valuation multiples (high P/E, P/S, EV/EBITDA), low or no dividends, and elevated price volatility in exchange for that expected expansion. The strategy is conventionally framed as the opposite pole from value investing: value buys a discount to assets or current earnings; growth buys a future trajectory. Its core, permanent tension is that the very thing that makes a growth stock attractive — a compelling expansion story — is also priced into the stock, so the investor's real edge is never "is this a good company growing fast?" but "is the actual growth going to exceed the growth already embedded in the price?" Every sub-topic in this branch is a different attack on that single question.

What this section covers

This is a section-overview node. It defines growth investing as a philosophy and maps its sub-topics; the operational depth lives in the child docs, which should be read directly rather than re-summarized here:

• [Identifying Secular Growth] — distinguishing durable, structural demand (technology adoption, demographics, policy) from cyclical or narrative growth that reverses with the economy. This is the front-end thesis: identifying a real, investible trend early on its S-curve.
• [Reinvestment Runways] — the engine of compounding: a high return on incremental invested capital (ROIIC) plus a long runway to keep deploying capital at that return. Separates a true compounder from a high-return business with nowhere to redeploy cash (a "legacy moat" that should pay dividends instead).
• [Paying Up for Quality] — the discipline (and the trap) of buying a superior business at a premium multiple, deliberately trading a margin of safety on price for a margin of safety on business durability.
• [Growth Trap Risks] — the risk counterweight: the stock priced for hyper-growth that fails to deliver, suffering both an earnings disappointment and multiple compression. The growth-side mirror of the value trap.

Together these four form a complete loop: find the trend (secular growth), confirm it compounds (reinvestment runways), decide what it's worth paying (paying up for quality), and guard against the failure mode (growth traps).

Origins and the core mechanics

Growth investing's intellectual founders are Philip Fisher (Common Stocks and Uncommon Profits, 1958), credited as "the father of growth investing" and originator of the "scuttlebutt" method — gathering qualitative intelligence from customers, suppliers, competitors, and ex-employees to judge a company's prospects beyond its financials — and Thomas Rowe Price Jr., who founded T. Rowe Price in 1937 around buying companies early in their growth phase and interviewing management before purchase (Wikipedia, Philip Arthur Fisher; Quartr, Thomas Rowe Price Jr.). Buffett famously described himself as "85% Graham and 15% Fisher," the Fisher portion being the quality-growth instinct.

Mechanically, growth investors prioritize forward characteristics over current cheapness: earnings growth, revenue/sales growth, and margin expansion, plus large addressable markets, leadership position, and reinvestment capacity (Fidelity, Growth vs Value; NerdWallet). Because dividends are minimal, the entire return is expected to come from price appreciation tracking the company's compounding intrinsic value. The arithmetic underneath every sub-node is the same identity that recurs throughout this branch: intrinsic value compounds at roughly reinvestment rate × return on incremental capital, sustained for as long as the moat protects it — which is why durability estimation, not growth detection, is where the work and the risk concentrate.

When it matters vs. when it doesn't

Growth investing is a multi-year, low-turnover buy-and-hold discipline. It matters when the holding horizon is long enough for compounding to dominate the entry multiple, the business has a defensible moat early on its adoption curve, and the investor can tolerate severe drawdowns without selling. It matters less, or works against you, late in a thematic cycle when narratives are crowded and multiples are stretched, or in regimes where the discount rate is rising (long-duration equities — those whose value sits in far-future cash flows — are the most exposed when rates rise). It has essentially no short-horizon / swing-trading application: a secular tailwind can be a contextual reason to favor a name's long side, but the thesis itself is a fundamental, multi-quarter-to-multi-year judgment, not an entry/exit tool.

Adoption, debate & evidence

Growth as a style is mainstream and uncontested — it anchors a major share of index methodology (growth vs. value index splits) and the fund industry. What is genuinely contested is the growth-vs-value performance record, and the picture is regime-dependent and honest only if both sides are stated:

• Long run, value led. Fama-French data is the standard reference: from 1926 to roughly 2021, value (low price-to-book) stocks outperformed growth by approximately 3–5% annually on average — the documented "value premium" (commonly cited from Fama-French research; magnitudes vary by sample and definition). The academic literature (Lakonishok-Shleifer-Vishny 1994; Chan-Karceski-Lakonishok 2003) attributes much of this to investors naively extrapolating recent growth that does not persist — the empirical foundation of the growth-trap node.
• Recent decade, growth led — sharply. Over roughly the decade to the early 2020s, growth reversed the historical pattern, with multiple sources reporting growth outpacing value by around 4–5% per year (e.g. value ~9.9% vs growth ~14.4% annualized in one widely cited account; figures vary by index and window). Commentators attribute this to near-zero interest rates, quantitative easing, and a secular-stagnation backdrop favoring long-duration growth (New Capital Management; J.P. Morgan Asset Management). Whether this is a permanent structural shift or a mean-reverting outlier is the live, unresolved debate.

The honest synthesis: the quality component embedded in good growth (high, stable ROIC) carries a genuine, well-documented premium (Asness-Frazzini-Pedersen, Quality Minus Junk), but sustained high earnings growth is not reliably forecastable — long-term growth rates mean-revert and analyst long-term forecasts are systematically too optimistic (Chan-Karceski-Lakonishok 2003). Growth investing's edge therefore lives in the rare durable compounders, not in the average growth name, and the average expensive-but-slow-actual-growth name is a documented underperformer. These figures are period- and definition-dependent point estimates; treat them as directional, not constants.

Strengths & limitations

Works best with genuinely durable, moated compounders held for years, where internal compounding swamps a rich entry multiple. Fails when (a) cyclical or narrative growth is mistaken for secular, (b) the growth runway is shorter or less defensible than the price assumes (multiple compression), or (c) the investor cannot hold through the inevitable deep drawdown. The #1 misuse across the whole branch is identical: treating a compelling growth narrative as a license to ignore valuation. A real trend at a too-high price is still a poor investment — the discipline is underwriting how much growth is already in the price.

Sources

• Wikipedia, Philip Arthur Fisher — father of growth investing; scuttlebutt method; Common Stocks and Uncommon Profits (1958). https://en.wikipedia.org/wiki/Philip_Arthur_Fisher
• Quartr, Thomas Rowe Price Jr. — T. Rowe Price growth-stock philosophy, management interviews, 1937 founding. https://quartr.com/insights/investment-strategy/thomas-rowe-price-jr-from-the-great-depression-to-global-dominance
• Fidelity, Growth versus Value — style characteristics (earnings/sales/margin growth, high P/E, low dividends, volatility). https://www.fidelity.com/learning-center/investment-products/mutual-funds/2-schools-growth-vs-value
• NerdWallet, Growth vs. Value Stock Investing — definitions and contrast. https://www.nerdwallet.com/article/investing/value-vs-growth-investing-styles
• New Capital Management, An Exceptional Value Premium — long-run value premium (~3–5%/yr, 1926–2021) and recent value drawdown. https://www.newcapitalmgmt.com/news/an-exceptional-value-premium
• J.P. Morgan Asset Management, Value vs growth investing: a historical overview — recent growth outperformance and rate/QE drivers. https://am.jpmorgan.com/ch/en/asset-management/adv/insights/value-vs-growth-investing/
• Chan, Karceski & Lakonishok (2003), The Level and Persistence of Growth Rates, NBER w8282 — no reliable persistence in long-term earnings growth; analyst forecasts too optimistic.
• Asness, Frazzini & Pedersen, Quality Minus Junk — quality-factor premium underpinning durable-growth returns.
• Child nodes (this branch): Identifying Secular Growth, Reinvestment Runways, Paying Up for Quality, Growth Trap Risks.

Disputes flagged: the value-vs-growth performance record is regime-dependent and actively contested — value led long-run (Fama-French ~3–5%/yr to ~2021) but growth led the decade to the early 2020s (~4–5%/yr); whether the recent reversal is structural or mean-reverting is unresolved. All return figures are sample- and definition-dependent point estimates; treat as directional. The robust, less-contested finding is that long-term growth rates mean-revert and are hard to forecast, so growth's edge concentrates in rare durable compounders.